Organon (OGN) Capital Expenditures (2020 - 2026)

Organon has reported Capital Expenditures for 7 years, with the latest figure at $42.0 million in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 7.69% year-over-year to $42.0 million in Q2 2026; TTM through Jun 2026 was $170.0 million, a 1.19% increase from a year earlier, with the FY2025 full-year figure at $162.0 million, down 7.43% from the prior year.
• Capital Expenditures was $42.0 million for Q2 2026 at Organon, up from $37.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $79.0 million in Q4 2023, with the low at $32.0 million in Q2 2024.
• Average Capital Expenditures over 5 years is $47.9 million, with a median of $45.5 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures jumped 57.78% in 2023, then slumped 54.93% in 2024.
• Over 5 years, Capital Expenditures stood at $63.0 million in 2022, then climbed by 25.4% to $79.0 million in 2023, then sank by 30.38% to $55.0 million in 2024, then fell by 18.18% to $45.0 million in 2025, then declined by 6.67% to $42.0 million in 2026.
• The last three Capital Expenditures figures came in at $42.0 million (Q2 2026), $37.0 million (Q1 2026), and $45.0 million (Q4 2025), per Business Quant data.